Fastest growing Pharmaceuticals stocks over 5-years
| Company | CMP (Rs) | Profit CAGR (5 yrs, %) | Sales CAGR (5 yrs, %) | MCap (Rs m) | P/E (x) | D/E (Curr FY, x) | RoE (5 yrs, Avg. %) |
|---|---|---|---|---|---|---|---|
| INTRA INFOTECH | 8.8 | NM | 126.3% | 4,640 | 69.0 | 3.6 | 11.1% |
| TOHEAL PHARMA | 152.5 | 200.1% | 109.8% | 3,733 | NM | 0.4 | 3.1% |
| PHARMAIDS PH | 71.4 | NM | 93.2% | 2,516 | NM | 0.1 | 0.6% |
| GIAN LIFE CARE | 19.3 | 110.5% | 88.0% | 200 | 5.1 | 0.3 | 19.1% |
| SWAGRUHA INFRA | 3.5 | 129.0% | 79.8% | 239 | NM | 0.1 | 2.0% |
| BALAXI PHARMA | 79.1 | NM | 77.8% | 4,367 | 12.3 | 0.1 | 29.9% |
| BALAXI PHARMA | 79.1 | NM | 77.8% | 4,367 | 12.3 | 0.1 | 29.9% |
| RELISH PHARMA | 58.3 | 109.3% | 73.8% | 2,552 | 17.7 | 0.1 | 11.1% |
| VIVANZA BIOSCIENCES | 4.0 | NM | 60.0% | 162 | 227.6 | 1.1 | 7.7% |
| ACHYUT HEALTHCARE | 67.0 | NM | 55.9% | 1,127 | NM | 0.0 | 3.0% |
| DIPNA PHARMACHEM | 6.5 | 102.3% | 52.1% | 157 | NM | 0.5 | 17.8% |
| FABINO LIFE | 28.0 | 224.1% | 50.2% | 59 | NM | 0.3 | 3.0% |
| YATHARTH HOSPITAL | 613.9 | 95.8% | 45.8% | 52,699 | 40.8 | 0.1 | 22.8% |
| INDEGENE LTD. | 636.8 | 88.7% | 36.2% | 152,354 | NM | 0.3 | 25.8% |
| BETA DRUGS | 1,440.4 | 35.3% | 35.0% | 13,848 | NM | 0.1 | 21.7% |
| COMBAT DRUGS | 15.5 | NM | 34.8% | 156 | 18.7 | 0.0 | 13.2% |
| GUJ.THEMIS. | 316.8 | 56.0% | 32.8% | 34,515 | 65.5 | 0.0 | 41.9% |
| FREDUN PHARMA | 685.1 | 28.5% | 29.1% | 3,235 | 18.3 | 0.9 | 8.8% |
| SHREE GANESH REMEDIES | 667.1 | 35.1% | 29.0% | 8,564 | 30.1 | 0.3 | 21.3% |
| BAFNA PHARMA | 80.0 | NM | 28.4% | 1,893 | 466.1 | 0.3 | 8.6% |
| MAX HEALTHCARE INSTITUTE | 999.2 | NM | 26.2% | 971,354 | 91.7 | 0.1 | 7.6% |
| SIGACHI INDUSTRIES | 48.0 | 24.7% | 25.3% | 15,989 | 24.6 | 0.3 | 22.6% |
| JEENA SIKHO | 1,945.0 | 63.1% | 25.1% | 48,353 | NM | 0.0 | 35.6% |
| INNOVA CAPTAB LTD. | 986.5 | 36.6% | 24.9% | 56,452 | 47.7 | 0.3 | 23.1% |
| AMI ORGANICS | 2,119.1 | 15.9% | 24.6% | 86,742 | 90.6 | 0.3 | 18.4% |
* We show NM where the values are negative
Disclaimer: This is for information purposes only. These are not stock recommendations and should not be treated as such. Learn more about our recommendation services here... Also note that these screeners are based only on numbers. There is no screening for management quality.
Equitymaster's powerful BSE/NSE Stock Screener allows you to screen stocks based on both pre-set and your own criteria.